fbpx
A patient with MDR-TB receives bedaquiline, one of the first new TB medicines in nearly 50 years, at the start of the endTB clinical trial in Almaty, Kazakhstan. (Photo by Yekaterina Sahabutdinova / PIH)

Groundbreaking Kazakhstan TB Trial Continuing Amid COVID-19 Challenges

Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…

UGHE Graduation: Scholar Gloria Igihozo Reflects on Activism, Equity

At the University of Global Health Equity (UGHE), a Partners In Health initiative in northern Rwanda, the graduating class of master’s students have had a memorable year. Despite a time of global uncertainty, the COVID-19 pandemic has presented new learning opportunities through UGHE’s quality online teaching, offered a new dimension to health curricula, and Read more…

SUBSCRIBE